JC Kips, BJ O'Connor, SJ Langley… - American journal of …, 2003 - atsjournals.org
Antagonizing the effect of interleukin (IL)-5 is a potential new treatment strategy in allergic
disorders. We evaluated the safety, biological activity, and pharmacokinetics of SCH55700 …